Author:
Kaur Balveen,Barth Rolf F.
Reference146 articles.
1. Adam, J F, Joubert, A, Biston, M C, Charvet, A M, Peoc'h, M, Le Bas, J F, Balosso, J, Esteve, F, Elleaume, H (2006) Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 64:603–611
2. Aghi, M, Chou, T C, Suling, K, Breakefield, X O, Chiocca, E A (1999) Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies. Cancer Res 59:3861–3865
3. Ahmed, A E, Jacob, S, Nagy, A A, Abdel-Naim, A B (2008) Dibromoacetonitrile-induced protein oxidation and inhibition of proteasomal activity in rat glioma cells. Toxicol Lett 179:29–33
4. Ali, S, Curtin, J F, Zirger, J M, Xiong, W, King, G D, Barcia, C, Liu, C, Puntel, M, Goverdhana, S, Lowenstein, P R, Castro, M G (2004) Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression. Mol Ther 10:1071–1084
5. Andersson, U, Grankvist, K, Bergenheim, A T, Behnam-Motlagh, P, Hedman, H, Henriksson, R (2002) Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation. Med Oncol 19:1–9